Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/03/2003WO2003026395A2 Mo54 gene disruptions, compositions and methods related thereto
04/03/2003WO2003026394A2 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto
04/03/2003WO2003012438A3 Method and means for detecting internal larval infestation in granular material
04/03/2003WO2003011395A3 Method of utilizing neurotrophins to manipulate reproductive capacity
04/03/2003WO2003008964A3 A method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
04/03/2003WO2003006977A3 Layered composite and micromechanical sensor element, in particular gas sensor element comprising said layered composite
04/03/2003WO2003006487A8 Modulation of phosphoinositide 3-kinase activity
04/03/2003WO2003006104A3 Lymphatic endothelial cells materials and methods
04/03/2003WO2003002978A3 Directed enzymatic modification of analytes for affinity capture and analysis
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2003001964A3 Measurement testing of blood specimens
04/03/2003WO2002103333B1 Method of high throughput haze screening of material
04/03/2003WO2002101354A3 Rapid methods for microbial typing and enumeration
04/03/2003WO2002100337A3 Antithrombotic thrombin variants
04/03/2003WO2002099052A3 Opns as modifiers of the p53 pathway and methods of use
04/03/2003WO2002099051A3 Nits as modifiers of the p53 pathway and methods of use
04/03/2003WO2002092761A3 Screening assays for agonists or antagonists of cd40 signaling
04/03/2003WO2002089736A3 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
04/03/2003WO2002088839A3 Method of transferring molecules to a coated film laminate having an ionic surface
04/03/2003WO2002088338A3 Method for replicating the hepatitis c virus
04/03/2003WO2002086495A3 Apparatus and method for determining the viability of eggs using ir-measurements
04/03/2003WO2002081742A3 Method for the detection of cytochrome b mutations in fungi
04/03/2003WO2002081523A3 Method for preparing and selecting antibodies
04/03/2003WO2002078520A3 IL-1ss INHIBITION FOR MYELOMA AND RELATED DISORDERS
04/03/2003WO2002077178A3 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use
04/03/2003WO2002074984A3 Biosensor, device and method for detecting nucleic acids by means of at least two units for immobilizing nucleic acids
04/03/2003WO2002073605A3 Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
04/03/2003WO2002073213A3 Assay
04/03/2003WO2002073206A3 Metabolic phenotyping in therapy with anxiolytics
04/03/2003WO2002073153A3 Module for an analysis device, applicator as an exchange part of the analysis device and analysis device associated therewith
04/03/2003WO2002071073A3 Screening system based on expression of abcg2 half transporter protein
04/03/2003WO2002071061A3 Quantitative detection of the conformation changes of p-glycoprotein
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES
04/03/2003WO2002064097A3 Vegf-d expression in brain cancer
04/03/2003WO2002063939B1 Method and system for fecal and ingesta detection during meat and poultry processing
04/03/2003WO2002061409A3 Mass spectrometric analysis of complex mixtures of immune system modulators
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002057413A3 Peptides for activation and inhibition of delta pkc
04/03/2003WO2002056753A3 P27 prevents cellular migration
04/03/2003WO2002056057A3 Dotted micro-array data extraction method
04/03/2003WO2002055739A3 Nucleic acid extraction solution and use thereof
04/03/2003WO2002053768A3 Dna rapid immune detection methods and apparatus
04/03/2003WO2002050529A3 Acoustic method for estimating mechanical properties of a material and apparatus therefor
04/03/2003WO2002044728A3 Chemical compositions comprising crystalline colloidal arrays
04/03/2003WO2002044419A3 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002039086A3 Glucose sensor system
04/03/2003WO2002031492A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like
04/03/2003WO2002031487A3 Ultrasonic austenitic weld seam inspection method and apparatus
04/03/2003WO2002031463A9 High density column and row addressable electrode arrays
04/03/2003WO2002025630A9 Microfabricated ultrasound array for use as resonant sensors
04/03/2003WO2002025286A9 Methods for the diagnosis of neoplastic disorders using angiogenin
04/03/2003WO2002025270A9 Screening systems and methods for identifying modulators of xenobiotic metabolism
04/03/2003WO2002024943A9 Method of identifying osteoregenerative agents using differential gene expression
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002023178A9 Method and system for detecting and recording submicron sized particles
04/03/2003WO2002022874A9 Oligonucleotides for labeling oligonucleotide probes and proteins
04/03/2003WO2002018951A3 Methods employing fluorescence quenching by metal surfaces
04/03/2003WO2002018544A9 Method and reagents for treatment of skin disorders by modulating the notch pathway
04/03/2003WO2002014539A9 Bioreactor and bioprocessing technique
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002012897A9 Automated information processing in randomly ordered arrays
04/03/2003WO2002012894A9 Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein
04/03/2003WO2002010770A3 Improved methods for identifying reagents which inhibit tau polymerization
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002005930A9 Device and methods for subdividing and filtering gel material and extracting molecules therefrom
04/03/2003WO2002003919A9 Structural targets in hepatitis c virus ires element
04/03/2003WO2002000934A3 Multiply-primed amplification of nucleic acid sequences
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030066099 SCCE modified transgenic mammals and their use as models of human disease
04/03/2003US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
04/03/2003US20030065480 Method of collecting measurement data during automatically milking an animal
04/03/2003US20030065452 High throughput functional genomics
04/03/2003US20030065417 Methods for engineering and manufacturing score-line-crack- resistant linerboard
04/03/2003US20030065277 Method and apparatus for measuring factors in mammary fluids
04/03/2003US20030065275 Metabolic calorimeter employing respiratory gas analysis
04/03/2003US20030065274 Method of respiratory gas analysis using a metabolic calorimeter
04/03/2003US20030065273 Metabolic calorimeter employing respiratory gas analysis
04/03/2003US20030065257 Diet and activity monitoring device
04/03/2003US20030065160 Secreted protein HEMAE80
04/03/2003US20030065159 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
04/03/2003US20030065061 A polymeric material void of endocrine disruptive chemicals comprising a monomer(ethylene or propylene) wherein monomer is processed without additon of other additive to form polyethylene or polypropylene; use in baby bottles, baby toys
04/03/2003US20030064970 Compounds and therapies for the prevention of vascular and non-vascular pathologies
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064926 Angiostatin fragments and method of use
04/03/2003US20030064925 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064923 Autoimmune disease; antiarthritic agents; genetic engineering
04/03/2003US20030064917 Methods and compositions for inhibiting angiogenesis
04/03/2003US20030064916 Antigen peptides; medical diagnosis
04/03/2003US20030064648 Degree of volatilization of a volatile agent can be visually checked by developing colors
04/03/2003US20030064529 Apparatus for use in the detection of lead concentration in the air
04/03/2003US20030064527 Proteomic differential display
04/03/2003US20030064526 Apparatus for se in recovery and transfer of fluid samples
04/03/2003US20030064525 Apparatus for use in the detection of preferential particle in bodily fluids
04/03/2003US20030064524 Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography
1 ... 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 ... 3937